Balyasny Asset Management LLC Teva Pharmaceutical Industries LTD Transaction History

Balyasny Asset Management LLC

  • $54.9 Billion
  • Q2 2024

A detailed history of Balyasny Asset Management LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Balyasny Asset Management LLC holds 3,742,969 shares of TEVA stock, worth $65.5 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
3,742,969
Previous 3,121,998 19.89%
Holding current value
$65.5 Million
Previous $44.1 Million 38.07%
% of portfolio
0.11%
Previous 0.08%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$12.78 - $17.4 $7.94 Million - $10.8 Million
620,971 Added 19.89%
3,742,969 $60.8 Million
Q1 2024

May 13, 2024
BUY
$10.67 - $14.43 $33.3 Million - $45.1 Million
3,121,998 New
3,121,998 $44.1 Million
Q3 2023

Nov 14, 2023
BUY
$7.48 - $10.7 $4.19 Million - $5.99 Million
559,518 New
559,518 $5.71 Million
Q1 2023

May 15, 2023
BUY
$8.36 - $11.37 $713,634 - $970,577
85,363 Added 4.73%
1,888,903 $16.7 Million
Q4 2022

Feb 14, 2023
BUY
$7.95 - $9.48 $14.3 Million - $17.1 Million
1,803,540 New
1,803,540 $16.4 Million
Q2 2022

Aug 15, 2022
BUY
$7.38 - $10.4 $12.8 Million - $18.1 Million
1,735,919 Added 192.13%
2,639,446 $19.8 Million
Q1 2022

May 16, 2022
BUY
$7.33 - $9.39 $6.48 Million - $8.3 Million
883,783 Added 4476.21%
903,527 $8.48 Million
Q4 2021

Feb 14, 2022
BUY
$7.9 - $10.19 $155,977 - $201,191
19,744 New
19,744 $158,000
Q2 2019

Aug 14, 2019
SELL
$8.12 - $15.72 $13 Million - $25.1 Million
-1,596,027 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$15.58 - $20.01 $12.7 Million - $16.3 Million
813,862 Added 104.05%
1,596,027 $25 Million
Q4 2018

Feb 14, 2019
SELL
$14.59 - $23.84 $12.3 Million - $20.1 Million
-844,463 Reduced 51.91%
782,165 $12.1 Million
Q3 2018

Nov 14, 2018
BUY
$21.06 - $25.65 $14.1 Million - $17.2 Million
670,720 Added 70.17%
1,626,628 $35 Million
Q2 2018

Aug 14, 2018
SELL
$16.77 - $24.71 $10.5 Million - $15.4 Million
-624,548 Reduced 39.52%
955,908 $23.2 Million
Q1 2018

May 15, 2018
BUY
$16.68 - $22.07 $17.1 Million - $22.6 Million
1,024,166 Added 184.11%
1,580,456 $27 Million
Q4 2017

Feb 14, 2018
SELL
$11.23 - $19.1 $12.2 Million - $20.8 Million
-1,089,636 Reduced 66.2%
556,290 $10.5 Million
Q3 2017

Nov 14, 2017
BUY
$15.41 - $32.17 $25.4 Million - $52.9 Million
1,645,926
1,645,926 $29 Million

Others Institutions Holding TEVA

# of Institutions
617
Shares Held
563M
Call Options Held
25.2M
Put Options Held
5.08M
View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Quotes by TradingView
  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email